Metropolitan Life Insurance CO Talaris Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jun 20, 2023	BUY	$4.51 - $9.85 $7,288 - $15,917	1,616 New	1,616 $7,000
Q2 2022 Mar 30, 2023	SELL	$4.51 - $9.85 $25,328 - $55,317	-5,616 Reduced 77.65%	1,616 $7,000
Q2 2022 Aug 11, 2022	BUY	$4.51 - $9.85 $7,288 - $15,917	1,616 New	1,616 $7,000
Q1 2022 May 12, 2022	SELL	$6.89 - $16.56 $49,828 - $119,761	-7,232 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$12.18 - $17.0 $88,085 - $122,944	7,232 New	7,232 $110,000
Q4 2021 Mar 30, 2023	BUY	$12.18 - $17.0 $88,085 - $122,944	7,232 New	7,232 $110,000
Q4 2021 Feb 15, 2022	BUY	$12.18 - $17.0 $88,085 - $122,944	7,232 New	7,232 $111,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.